| Today's News and Trends | Aidence will license, develop, and validate Google Health’s existing AI research module, hoping to offer better differentiation between benign and malignant lung nodules at an early stage. Aidence will license, develop, and validate Google Health’s existing AI research module, hoping to offer better differentiation between benign and malignant lung nodules at an early stage. | |
| A patient survey revealed that more than one in five women would likely skip indicated follow-up screenings if they had to pay a deductible, even if an initial mammogram revealed abnormalities. A patient survey revealed that more than one in five women would likely skip indicated follow-up screenings if they had to pay a deductible, even if an initial mammogram revealed abnormalities. | |
| | “The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022. “The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022. | |
| Ransomware is a growing problem for healthcare providers. At RSNA 2022, two experts examined how leaders can protect their teams and their facilities. Ransomware is a growing problem for healthcare providers. At RSNA 2022, two experts examined how leaders can protect their teams and their facilities. | |
| | Isotopic labeling is time-consuming and expensive. Now, a new development in isotopic labeling heralds a new way to prepare imaging agents. Isotopic labeling is time-consuming and expensive. Now, a new development in isotopic labeling heralds a new way to prepare imaging agents. | |
| “The RSNA will maintain our position as the great convener for all those who interact with our members to advance the fields of diagnostic radiology, interventional radiology, radiation oncology and medical physics," Mauro said. “The RSNA will maintain our position as the great convener for all those who interact with our members to advance the fields of diagnostic radiology, interventional radiology, radiation oncology and medical physics," Mauro said. | |
| | Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share. Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share. | |
| As healthcare devices become ever more digitally connected and network capabilities expand with new technology, the threat of cyberattacks is rising. As healthcare devices become ever more digitally connected and network capabilities expand with new technology, the threat of cyberattacks is rising. | |
| |
|
| | |
|